(Reuters) - Express Scripts Holding Co on Tuesday announced a new drug reimbursement list with lower U.S. prices for brand-name medications, as a way to encourage drugmakers to move away from paying ...

Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...

Express Scripts will be releasing a stand-alone formulary in 2020 that highlights vetted digital health tools for the pharmacy benefit management firm’s payer and consumer customers, according to an ...

The inclusion of neffy on Express Scripts’ Commercial National Formularies significantly expands access to millions of commercially insured patients, improving availability of life-saving allergy ...

(Reuters) - Express Scripts Holding Co, the largest U.S. pharmacy benefit manager, on Friday said it will remove 25 products from its 2015 list of preferred drugs, including anemia treatments Epogen ...

Express Scripts is switching its formulary preference to insulin biosimilar Semglee, a move that it claims will save members $20 million in 2022. Mylan’s Semglee is the first interchangeable ...

LONDON (Reuters) - GlaxoSmithKline received a boost on Monday from a decision by Express Scripts , the largest U.S. pharmacy benefit manager, to reinstate its top-selling lung drug Advair as an ...

Trividia Health, Inc. Announces Preferred Listing of the TRUE METRIX® Blood Glucose Meters and Test Strips on the Express Scripts Commercial National Preferred Formulary Providing accurate and ...

Express Scripts was the first to cap out-of-pocket costs for insulin medications at $25 for a 30-day supply in 2019, well before the government took action "The fact is that in the unlikely event the ...

Nation’s largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers. NEW YORK--(BUSINESS WIRE)--Today, Bernstein Litowitz Berger & ...

Company's immunology franchise demonstrates strong market momentum with preferred status under one of the largest pharmacy benefit managers in the nation IMULDOSA, a biosimilar to STELARA® ...